Expedeon logo — Experts in innovative life sciences and diagnostics solution...

Expedeon

Experts in innovative life sciences and diagnostics solutions for all your research and manufacturing needs

Founded 2002 1001-5000 employees Debt Financing Total: $5.24M Biotechnology, Life Sciences

General Information

Company Name Expedeon
Founded Year 2002
Employees 1001-5000
Industries Biotechnology, Life Sciences
Funding Stage Debt Financing
Social

Get notified when Expedeon moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Expedeon

Expedeon is a biotechnology and life sciences startup focusing on innovative reagents and services. Established in 2002, the company offers a wide range of solutions for protein electrophoresis, liquid biopsy, whole genome amplification, antibody- and protein-labeling, and immunoassay development. Its portfolio includes ready-to-use products and customized services, catering to the needs of scientists from academic institutions to commercial manufacturers. Expedeon, owned by SYGNIS AG, operates in the UK, USA, Singapore, Germany, and Spain. The company received a £5.00M debt financing investment from BOOST&Co on 30 August 2018. The company's commitment to delivering high-quality, user-friendly, and cost-effective solutions positions it well to capitalize on the growing demand for innovative life sciences and diagnostics solutions. With its global delivery capabilities and a focus on reducing hands-on time for researchers, Expedeon is poised for continued growth and success in the industry.

Taxonomy: Life Sciences, Diagnostics, Innovative Reagents, Protein Electrophoresis, Liquid Biopsy, Genomics, Proteomics, Antibody Labeling, Bioconjugation, Nanoparticle Conjugation, Customized Services, Quality Control Testing, Global Delivery, Research and Development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• 1
Investor
30 Aug 2018
Venture Round •••••• 1
Investor
22 Sep 2014

Expedeon Alternatives & Competitors

Expedeon vs

Full line proteomics services

4 employees
Health Care, Medical Devices
Expedeon vs

Protein with integrity. It’s what we serve and how we serve our people, suppliers, and customers.

Debt Financing
108 employees
Food and Beverage
Expedeon vs
iChemLabs, LLC.
iChemLabs, LLC. United States

Essential Tools for Accomplished Chemists

2 employees
IT

FAQ About Expedeon

Experts in innovative life sciences and diagnostics solutions for all your research and manufacturing needs
Expedeon was founded in 2002.
Expedeon operates in the following industries: Biotechnology, Life Sciences.
Expedeon has approximately 1001-5000 employees.
Expedeon has completed 2 funding rounds, raising a total of $5.24M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Expedeon include Applied Biomics, Deli Star Corporation, iChemLabs, LLC., Improved Nature®, LifeTein.com. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Expedeon and Applied Biomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Expedeon and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy